Anzeige
Mehr »
Mittwoch, 03.09.2025 - Börsentäglich über 12.000 News
Geheime Uran-Aktie: Ist das der historische "New Deal"-Moment für amerikanischen Uransektor?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0F5F5 | ISIN: US1248051021 | Ticker-Symbol: XC4
Tradegate
02.09.25 | 15:48
54,00 Euro
-2,70 % -1,50
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
CBIZ INC Chart 1 Jahr
5-Tage-Chart
CBIZ INC 5-Tage-Chart
RealtimeGeldBriefZeit
54,0055,5012:12
54,0055,5010:03

Aktuelle News zur CBIZ Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
Mo$1000 Invested In CBIZ 15 Years Ago Would Be Worth This Much Today2
19.08.CBIZ, Inc.: CBIZ Names Jennifer Hutchins Chief Investment Officer of Investment Advisory Services156Cleveland, Aug. 19, 2025 (GLOBE NEWSWIRE) -- CBIZ, Inc., a leading national professional services advisor, today announced that it has named Jennifer Hutchins as Chief Investment Officer of CBIZ Investment...
► Artikel lesen
07.08.William Blair Remains Bullish on CBIZ, Inc. (CBZ)1
05.08.CBIZ, Inc.: CBIZ Launches Comprehensive Employee Experience Guide to Help Businesses Unlock the Full Potential of Their People1
31.07.CBIZ, Inc. - 10-Q, Quarterly Report1
CBIZ Aktie jetzt für 0€ handeln
31.07.CBIZ anticipates revenue at low end of $2.8B-$2.95B guidance amid persistent market headwinds and Marcum integration4
31.07.CBIZ Q2 2025 presentation: Marcum acquisition drives 66% revenue growth, outlook affirmed2
30.07.CBIZ, Inc. - 8-K, Current Report-
24.07.SUNation Energy ernennt CBIZ CPAs zum neuen Wirtschaftsprüfer1
16.07.CBIZ, Inc: CBIZ to Announce Second-Quarter and First-Half 2025 Results on July 30, 20252
13.06.InMed Pharmaceuticals: InMed Appoints CBIZ as New Auditor in Connection with CBIZ's Acquisition of Marcum's Attest Business, Provides Update on Special Meeting and Makes Modifications to Existing SEPA970Vancouver, British Columbia--(Newsfile Corp. - June 13, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...
► Artikel lesen
25.04.CBIZ, Inc. - 10-Q, Quarterly Report2
24.04.CBIZ, Inc. - 8-K, Current Report1
24.04.CBIZ Q1 2025 presentation: Revenue surges 69.5% following Marcum acquisition2
24.04.CBIZ Non-GAAP EPS of $1.63, revenue of $838M1
24.04.CBIZ, Inc.: Cbiz Reports First-quarter 2025 Results115FIRST-QUARTER HIGHLIGHTS: TOTAL REVENUE UP 69.5% NET INCOME UP 59.7%; GAAP DILUTED EPS UP 24.8% ADJUSTED EBITDA UP 100.0%; ADJUSTED DILUTED EPS UP 40.5% MARCUM...
► Artikel lesen
23.04.A Peek at CBIZ's Future Earnings1
10.04.Here's Why Headwaters Capital Management Added CBIZ (CBZ) to its Portfolio1
11.03.CBIZ Board Member Sold $468K In Company Stock3
26.02.CBIZ, Inc.: Cbiz Reports Fourth-quarter And Full-year 2024 Results184FOURTH-QUARTER HIGHLIGHTS: MARCUM ACQUISITION CLOSED NOVEMBER 1, 2024 FOURTH-QUARTER REVENUE UP 40.5%; SAME-UNIT REVENUE UP 6.4% RESULTS INCLUDE MARCUM TRANSACTION...
► Artikel lesen
Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1